ATE215953T1 - Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften - Google Patents

Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften

Info

Publication number
ATE215953T1
ATE215953T1 AT97944309T AT97944309T ATE215953T1 AT E215953 T1 ATE215953 T1 AT E215953T1 AT 97944309 T AT97944309 T AT 97944309T AT 97944309 T AT97944309 T AT 97944309T AT E215953 T1 ATE215953 T1 AT E215953T1
Authority
AT
Austria
Prior art keywords
ced
ice
tricyclic compounds
inhibiting properties
protease family
Prior art date
Application number
AT97944309T
Other languages
German (de)
English (en)
Inventor
Donald S Karanewsky
Steven D Linton
Original Assignee
Idun Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idun Pharmaceuticals Inc filed Critical Idun Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE215953T1 publication Critical patent/ATE215953T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dentistry (AREA)
AT97944309T 1996-09-12 1997-09-12 Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften ATE215953T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2601196P 1996-09-12 1996-09-12
US71062196A 1996-09-20 1996-09-20
PCT/US1997/016156 WO1998011109A1 (en) 1996-09-12 1997-09-12 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes

Publications (1)

Publication Number Publication Date
ATE215953T1 true ATE215953T1 (de) 2002-04-15

Family

ID=26700599

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97944309T ATE215953T1 (de) 1996-09-12 1997-09-12 Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften

Country Status (8)

Country Link
EP (1) EP0874850B1 (Direct)
JP (1) JP2000501428A (Direct)
AT (1) ATE215953T1 (Direct)
AU (1) AU739496B2 (Direct)
CA (1) CA2237314A1 (Direct)
DE (1) DE69711845T2 (Direct)
NZ (1) NZ330451A (Direct)
WO (1) WO1998011109A1 (Direct)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610683B2 (en) * 1996-09-12 2003-08-26 Idun Pharmaceuticals, Inc. Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
US6184210B1 (en) 1997-10-10 2001-02-06 Cytovia, Inc. Dipeptide apoptosis inhibitors and the use thereof
DE69925581T2 (de) 1998-03-09 2006-04-27 Vertex Pharmaceuticals Inc., Cambridge 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
DE69925268T2 (de) * 1998-03-16 2006-03-23 Cytovia, Inc., San Diego Dipeptid-Caspase-Inhibitoren und deren Verwendung
IL138469A0 (en) 1998-03-19 2001-10-31 Vertex Pharma Caspase inhibitors and pharmaceutical compositions containing the same
KR20010110667A (ko) 1999-03-16 2001-12-13 추후보정 치환 2-아미노벤즈아미드 카스파제 저해제 및 그것의 용도
AU4213500A (en) 1999-04-09 2000-11-14 Cytovia, Inc. Caspase inhibitors and the use thereof
WO2001010383A2 (en) * 1999-08-06 2001-02-15 Vertex Pharmaceuticals Incorporated Caspase inhibitors and uses thereof
WO2001016093A1 (en) 1999-08-27 2001-03-08 Cytovia, Inc. SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF
CA2386411A1 (en) * 1999-10-13 2001-04-19 Merck Frosst Canada & Co. Nicotinyl aspartyl ketones as inhibitors of caspase-3
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
AU7527901A (en) 2000-06-07 2001-12-17 Vertex Pharma Caspase inhibitors and uses thereof
AU2005249503B2 (en) 2003-11-10 2011-08-25 Vertex Pharmaceuticals Incorporated ICE inhibitors for the treatment of autoinflammatory diseases
JP4898658B2 (ja) 2004-03-12 2012-03-21 バーテックス ファーマシューティカルズ インコーポレイテッド アスパラギン酸アセタールカスパーゼ阻害剤の製造のための方法および中間体
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
CA2616337A1 (en) 2005-07-28 2007-02-08 Vertex Pharmaceuticals Incorporated Caspase inhibitor prodrugs
US9956260B1 (en) 2011-07-22 2018-05-01 The J. David Gladstone Institutes Treatment of HIV-1 infection and AIDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504080A (en) * 1992-10-28 1996-04-02 Bristol-Myers Squibb Co. Benzo-fused lactams
EP0706525A1 (en) * 1993-06-30 1996-04-17 Novartis AG Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace

Also Published As

Publication number Publication date
EP0874850A1 (en) 1998-11-04
WO1998011109A1 (en) 1998-03-19
DE69711845D1 (de) 2002-05-16
JP2000501428A (ja) 2000-02-08
CA2237314A1 (en) 1998-03-19
DE69711845T2 (de) 2002-10-31
AU739496B2 (en) 2001-10-11
NZ330451A (Direct) 2000-01-28
EP0874850B1 (en) 2002-04-10
AU4583597A (en) 1998-04-02

Similar Documents

Publication Publication Date Title
ATE215953T1 (de) Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften
HK1042502A1 (zh) 用作ice/ced-3族半胱氨酸蛋白酶抑制劑的c-端修飾的(n-取代)-2-吲基二肽
MXPA00013014A (es) Dipe`tidos de oxamilos modificados en el extremo carboxi como inhibidores de la familia ice/ced-3 de proteasas de cisteinas.
IL128940A0 (en) C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases and pharmaceutical compositions containing them
WO2003072528A3 (en) (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
WO1992011850A3 (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
SG158733A1 (en) Cell adhesion inhibitors
FI962246A0 (fi) Apoptoosia inhiboivat koostumukset, koostumusten puhdistusmenetelmät ja niiden käyttö
PT805796E (pt) Inibidores da adesao celular
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
BR0210904A (pt) Uso de inibidores de il-18 para o tratamento ou prevenção de sepse
FR07C0041I2 (fr) Beta-amino-tetrahydroimidazo(1, 2-a)pyrazines et beta-amino-tetrahydrotrioazolo(4, 3-a)pyrazines utilisees en tant qu'inhibiteurs de la dipeptidyl peptidase dans le traitement ou la prevention du diabete
MX9800348A (es) Inhibidores de adhesion celular.
EA200100732A1 (ru) Противовоспалительные и иммуносупрессорные соединения, ингибирующие клеточную адгезию
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
DE69229552D1 (de) Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau
NO20023962D0 (no) Bruk av IL-18-inhibitorer
DE60142313D1 (de) Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen
WO2002057298A3 (en) C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
NO20015673L (no) IL6RIL6 kimaere for behandlingen av nevrodegenerative sykdommer
MXPA03004450A (es) Compuestos triciclicos y sus usos.
NO20020369L (no) Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer
DE50002304D1 (en) Tyrosin- und tryptophanhaltige peptide als antioxidantien
ES2131468A1 (es) Uso de la melatonina en el tratamiento de las enfermedades neurodegenerativas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties